Clinical trial

Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)

Active, not recruiting · Not applicable · 1 countries · Registry ID NCT01745471

Active, not recruitingNot applicableObservational

What this study is about

The purpose of this study is to collect data to help understand why some women develop Polycystic Ovary Syndrome (PCOS) associated with decreased lower-body fat.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age20 Years to 40 Years
SexFemale
Healthy volunteersAccepted
ConditionPolycystic Ovary Syndrome, Metabolic Diseases, Overweight

Full registry criteria

Inclusion Criteria: * Female * Age \> 20 and \< 40 * Weight stable (change of less than 3 kg in the last 8 weeks) * BMI \< 40 kg/m2 or \> 27 kg/m2 Supplemental inclusion criteria for PCOS women: * NIH criteria - confirmed by subjects' medical records. Exclusion Criteria: * Male * Women who are pregnant or lactating (breast feeding) * Post-menopausal women * Women with hysterectomy * Diagnosed with diabetes, or have a fasting blood sugar \> 126 mg/dL. * Untreated or symptomatic thyroid disease. * Impaired kidney or liver function, as evidenced by your blood work * Hypertension/ high blood pressure or are taking blood pressure medications * Use of oral contraceptives or hormone replacement therapy. * History of drug or alcohol abuse (\> 3 drinks per day) in the last 5 years, or psychiatric disease prohibiting adherence to study protocol. * History of cancer within the last 5 years. * History of organ transplant. * History of HIV, active Hepatitis B or C, or Tuberculosis. * History of heart attack/ myocardial infarction. * Presence of clinically significant abnormalities on EKG. * Current smokers (smoking within the past 3 months) * Use of any medications known to influence glucose, fat and/or energy metabolism within the last 3 months (e.g., growth hormone therapy, glucocorticoids \[steroids\], etc.). Metformin for women with PCOS is allowed.

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Difference of angiogenesis capacity in abdominal and gluteal adipose tissueDay 7

The angiogenesis capacity of each adipose tissue depot will be determine by an in vitro angiogenesis test.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Translational Research Institute for Metabolism and Diabetes🇺🇸 Orlando, Florida, United States